HEM-iSMART: Evaluation of the activity of new drugs in T-ALL & T-LBL patients
HEM-iSMART trial studies tailored drug combinations for pediatric T-ALL/T-LBL based on specific tumor alterations.
The BSPHO unites the recognized Belgian centres in paediatric haemato-oncology and their professionals to share expertise and knowledge to improve treatment and patient care in childhood cancer
HEM-iSMART trial studies tailored drug combinations for pediatric T-ALL/T-LBL based on specific tumor alterations.
Sciensano seeks a part-time scientific staff member for pediatric cancer projects, focusing on palliative care, research, and policy support.
CUSL is seeking a Resident in Pediatric Hematology and Oncology for an exciting, educational, and clinically challenging position.
BSPHO coordinates the evacuation of four young cancer patients from Gaza, continuing its humanitarian support in conflict zones.
Join the BSPHO team for Run to Kick and help fund innovative cancer treatments for children - walk or run with us!
The 2nd BSPHO Scientific Meeting of 2025 will take place in October at the BSPHO office.
Symposium on latest advances in diagnosing and treating inborn errors of immunity, organised by UZ Gent on 9 October 2025.
Save the date for the BSPHO 2025 Symposium on Supportive Care in Paediatric Haemato-Oncology!